◼ Archived
Health
This Stock, Up Almost 70%, May Have Found Cancer's Holy 'Grail'
A multi-cancer early detection blood test draws investor enthusiasm and trial data coverage across major financial and health outlets.
Biotech Stocks
2 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
🔮 fades ✓
Why Vertex Pharma Popped, As A Key Rival Plummeted 90%
Vertex Pharmaceuticals shares rise as rival Sionna Therapeutics sees its stock collapse following a failed cystic fibrosis drug trial.